nivolumab for metastatic melanoma

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
nivolumab for metastatic melanoma	1.19	0.4	9391	10	33
nivolumab	0.42	0.8	3860	68	9
for	1.91	1	1034	53	3
metastatic	1.19	0.1	86	41	10
melanoma	1.9	0.6	8463	3	8

Keyword	CPC	PCC	Volume	Score
nivolumab for metastatic melanoma	1.26	0.9	601	75
ipilimumab and nivolumab metastatic melanoma	0.08	0.8	9904	51
ipilimumab nivolumab metastatic melanoma	1.02	1	7764	35
nivolumab immunotherapy for melanoma	1.11	0.4	6089	70
nivolumab and pembrolizumab for melanoma	1.41	0.8	9554	24
ipilimumab and nivolumab for melanoma	1.06	0.1	1750	7
relatlimab nivolumab melanoma nejm	1.53	1	6377	45
nivolumab for the treatment of cancer	0.14	0.4	5815	29
adjuvant nivolumab in melanoma	1.24	0.3	7772	8
monoclonal antibody melanoma nivolumab	1	0.5	4592	51
pembrolizumab versus nivolumab for melanoma	1.46	0.2	3323	42
nivolumab for renal cell metastasis	1.12	0.8	7727	35
nivolumab for renal metastases	0.3	0.4	7077	47
nice ipilimumab nivolumab melanoma	0.43	0.6	6654	1
relatlimab nivolumab melanoma fda approval	0.87	1	6424	78
nivolumab side effects melanoma	1.63	0.1	7112	46
nivolumab for liver cancer	0.78	0.2	3631	14
pembrolizumab vs nivolumab melanoma	1.11	0.8	7861	7
nivolumab for lung cancer	0.98	0.5	1880	32
nivolumab for mesothelioma nejm	1.46	0.1	1946	58
nivolumab for head and neck cancer	1.48	0.9	918	12
formular specific nivolumab melanom	0.31	0.1	6794	84